Adhera Therapeutics is a clinical stage biopharmaceutical company focused on identifying advanced drug candidates that may qualify for accelerated developmental pathways. The Company has recently licensed two drug candidates, MLR-1019 and MLR-1023, from the Melior Discovery family of companies. Adhe... Adhera Therapeutics is a clinical stage biopharmaceutical company focused on identifying advanced drug candidates that may qualify for accelerated developmental pathways. The Company has recently licensed two drug candidates, MLR-1019 and MLR-1023, from the Melior Discovery family of companies. Adhera is developing MLR-1023 (tolimidone) as a new drug for Type I diabetes with a focus on C-peptide positive patients. MLR-1023, a lyn kinase activator, has demonstrated exceptional clinical safety and tolerability in over 700 patients in Phase 2a and Phase 2b Type 2 diabetes studies. MLR-1019 (armesocarb) is a new class of drug for Parkinson's Disease (PD) and represents the only drug to address both movement and non-movement symptoms of PD. Armesocarb is the active enantiomer in mesocarb, a drug marketed in Europe for 37 years for various psychiatric and central nervous system indications. In addition to advancing both drug candidates in Phase 2 clinical trials, the Company remains active in exploring other advanced drug development opportunities while maintaining its legacy assets, including CEQ508, an oral delivery of small interfering RNA (siRNA) against beta-catenin, to suppress polyps in the precancerous syndrome and orphan indication Familial Adenomatous Polyposis (FAP). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 328782 | 0.0001 | CS |
4 | -0.0001 | -50 | 0.0002 | 0.0002 | 0.0001 | 165041 | 0.00010039 | CS |
12 | -0.0023 | -95.8333333333 | 0.0024 | 0.0024 | 0.0001 | 48801 | 0.000281 | CS |
26 | -0.0079 | -98.75 | 0.008 | 0.015 | 0.0001 | 29581 | 0.00372927 | CS |
52 | -0.0299 | -99.6666666667 | 0.03 | 0.03 | 0.0001 | 84596 | 0.01254103 | CS |
156 | -0.0654 | -99.8473282443 | 0.0655 | 1.09 | 0.0001 | 79548 | 0.03241074 | CS |
260 | -0.0499 | -99.8 | 0.05 | 1.09 | 0.0001 | 90907 | 0.11305696 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.